drugset

drugset / Trial / NCT07337564

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

NCT07337564 ↗

Phase 2 Not yet recruiting 10 enrolled Shandong First Medical University

NaSingle-groupOpen-labelTreatment

Summary

This study was designed to assess the therapeutic efficacy and safety of SHR-1139 Injection in adult patients with ulcerative pyoderma gangrenosum.

Timeline

Start: 2026-02-01
Primary completion: 2027-12
Completion: 2028-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SHR-1139	Unknown	—	—

Indications